Form D · Other Health Care

Meihua International Medical Technologies Co., Ltd.

Yangzhou, F4 · CIK 0001835615

Offering snapshot reported Jan 8, 2024 · SEC filing

Reported sold: $5.58M
Investors reported: 2
Minimum accepted: $1.12M
First sale: Dec 27, 2023

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

Filed	Filing type	Reported sold	Change vs linked filing	Investors	Source
Jan 8, 2024	Initial	$5,580,000	No comparison	2	SEC filing

Offering details

Securities: Option to acquire, Security to be acquired
Exemptions: 06b
Duration over one year: Yes
Business combination: No

Sales commissions: $391K
Finders' fees: $0
Form D file number: 021-501781

A private placement of 1,205,255 ordinary share purchase warrants were sold along with a 7% OID $6 million registered direct convertible note offering, which was the initial tranche of an up to $50.5 million offering, for gross proceeds of $5,580,000.

Maxim received a 7% commission in relation to the gross proceeds of the Offering as the sole placement agent, and reimbursement of $50,000 for its out-of-pocket expenses.

Sales compensation recipients

Scroll to see all columns →

Recipient	CRD	Associated broker-dealer
Maxim Group LLC	120708

Source: Form D, filed Jan 8, 2024. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
Name	Reported role
Xiaoming E	Director
Wenzhang Jia	Director
Yongjun Liu	Director
Xin Wang	Director, Executive
Lianzhang Zhao	Executive
Huijuan Zhao	Director

Issuer details

Industry: Other Health Care (See others in industry)

Address:

88 Tongda Road, Touqiao Town Guangling District
Yangzhou, F4, 225000